HLS Therapeutics Inc. (TSX:HLS)

HLS Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	13.73	11.72	17.46	21.95	20.72	21.18
Cash & Short-Term Investments	13.73	11.72	17.46	21.95	20.72	21.18
Cash Growth	12.98%	-32.84%	-20.48%	5.93%	-2.15%	2.75%
Accounts Receivable	7.88	7.05	6.72	9.64	8.91	9.77
Other Receivables	0.63	0.81	0.8	1.05	2.29	1.74
Receivables	8.51	7.86	7.53	10.69	11.19	11.51
Inventory	6.14	8.14	9.06	9.53	8.9	8.93
Prepaid Expenses	-	-	-	1.91	2.13	2.14
Other Current Assets	2.14	1.37	1.36	0	1.43	-
Total Current Assets	30.51	29.09	35.4	44.1	44.37	43.75
Property, Plant & Equipment	1.02	1.34	1	0.97	1.13	1.57
Other Intangible Assets	95.42	105.63	122.12	162.34	195.02	229.18
Long-Term Deferred Tax Assets	1.35	1.14	0.86	1.04	0.47	0.69
Other Long-Term Assets	0.25	0.33	0.53	0.62	0.67	0.71
Total Assets	128.55	137.53	159.9	209.06	241.65	275.91

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	8.4	10.44	8.71	14.11	11.59	9.32
Current Portion of Long-Term Debt	4.16	4.33	4.83	4.69	13.06	12
Current Portion of Leases	0.43	0.49	0.46	0.46	0.53	0.61
Current Income Taxes Payable	0.27	0.41	0.15	0.28	-	0.1
Other Current Liabilities	15.83	10.46	8.4	7.14	6.02	5.65
Total Current Liabilities	29.09	26.12	22.55	26.69	31.19	27.67
Long-Term Debt	37.02	44.45	60.74	82.05	83.28	84.13
Long-Term Leases	0.29	0.55	0.43	0.42	0.48	0.83
Long-Term Deferred Tax Liabilities	2.92	3.06	4.07	0.44	0.57	0.65
Other Long-Term Liabilities	3.99	1.67	0.78	1.77	0.82	1.88
Total Liabilities	73.31	75.86	88.56	111.36	116.33	115.17

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	256.3	256.34	260.6	262.13	265.21	265.92
Additional Paid-In Capital	15.34	16.16	15.14	13.87	13.82	11.72
Retained Earnings	-207.44	-204.15	-194.18	-175.46	-148.45	-119.86
Comprehensive Income & Other	-8.96	-6.68	-10.21	-2.84	-5.26	2.96
Shareholders' Equity	55.24	61.67	71.34	97.7	125.32	160.74
Total Liabilities & Equity	128.55	137.53	159.9	209.06	241.65	275.91

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	41.9	49.82	66.45	87.62	97.35	97.57
Net Cash (Debt)	-28.17	-38.1	-48.99	-65.67	-76.62	-76.39
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.90	-1.21	-1.54	-2.04	-2.36	-2.37
Filing Date Shares Outstanding	30.94	31.27	31.79	31.92	32.35	32.47
Total Common Shares Outstanding	31.27	31.27	31.79	31.98	32.36	32.45
Working Capital	1.42	2.97	12.86	17.41	13.18	16.08
Book Value Per Share	1.77	1.97	2.24	3.05	3.87	4.95
Tangible Book Value	-40.18	-43.96	-50.78	-64.65	-69.7	-68.45
Tangible Book Value Per Share	-1.28	-1.41	-1.60	-2.02	-2.15	-2.11
Machinery	-	1.4	1.18	1.17	1.12	1.08

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error